This was the case in an observational study of over 900 CRC patients published in 2012 by Liao et al. in which aspirin use significantly improved survival in patients with PIK3CA-mutant CRC, whereas survival in patients with wild-type PIK3CA CRC was not improved [30]. Here, PIK3CA is linked to colorectal carcinoma.